학술논문
Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on: M33
Document Type
Academic Journal
Author
Source
Thorax. Dec 01, 2017 72 Suppl 3:A255-A255
Subject
Language
English
ISSN
0040-6376